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Abstract
Background
Prenatal stress affects the health of the pregnant woman and the fetus. Cortisol blood levels
are elevated in pregnancy, and fetal exposure to cortisol is regulated by the placenta
enzyme 11β-HSD2. A decrease in enzyme activity allows more maternal cortisol to pass
through the placental barrier. Combining the fetal and maternal cortisol to cortisone ratio
into the adjusted fetal cortisol exposure (AFCE) represents the activity of the enzyme 11β-
HSD2 in the placenta.
Aim
To investigate the effect of prenatal maternal stress on the ratio of cortisol and cortisone in
maternal and fetal blood at birth in a normal population.
Method
Maternal self-reported stress was assessed at one time-point, as late in the pregnancy as
convenient for the participant, using the Depression Anxiety Stress Scales (DASS-42),
Pregnancy Related Anxiety (PRA), and Major Life Events during pregnancy. The study
included 273 participants from Copenhagen University Hospital. Maternal and umbilical
cord blood was sampled directly after birth and cortisol and cortisone concentrations were
quantified using UPLC chromatography. Data were analyzed in a five-step regression
model with addition of possible confounders. The primary outcome was AFCE, and plasma
concentrations of maternal and fetal cortisol and cortisone were secondary outcomes.
Results
Significant associations were seen for the primary outcome AFCE and the plasma concen-
trations of maternal cortisol and fetal cortisone with exposure to Pregnancy Related Anxiety
(PRA), though the associations were reduced when adjusting for birth related variables,
PLOS ONE | https://doi.org/10.1371/journal.pone.0207184 November 15, 2018 1 / 18
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Dahlerup BR, Egsmose EL, Siersma V,
Mortensen EL, Hedegaard M, Knudsen LE, et al.
(2018) Maternal stress and placental function, a
study using questionnaires and biomarkers at
birth. PLoS ONE 13(11): e0207184. https://doi.org/
10.1371/journal.pone.0207184
Editor: Cheryl S. Rosenfeld, University of Missouri
Columbia, UNITED STATES
Received: February 6, 2018
Accepted: October 26, 2018
Published: November 15, 2018
Copyright: © 2018 Dahlerup et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files. Some restrictions apply: Personally
identifiable data have been grouped due to
anonymization.
Funding: The Maternal Stress and Placental
Function project was funded by AFAAR/NEAVS (the
American Fund for Alternatives to Animal
Research/New England Anti-Vivisection Society
Fellowship Grant for Alternatives to Animal
Research in Women’s Health and Sex Differences)
especially delivery mode. The weight of the placenta affected the associations of exposures
on AFCE, but not plasma concentrations of cortisol and cortisone in mother and fetus. More-
over, the study demonstrated the importance of delivery mode and birth strain on cortisol
levels right after delivery.
Conclusion
Our main finding was associations between PRA and AFCE, which shows the effect of
maternal stress on placental cortisol metabolism.
Introduction
The prevalence of psychosocial stress and anxiety during pregnancy is a cause of concern
worldwide, and maternal psychosocial stress has been conceptualized as a teratogen [1].
Maternal and child mental health is addressed in the WHO Mental Health Action Plan (2013–
2020), in which it is estimated that about 10% of pregnant women have experienced mental
health problems, primarily depression, and this percentage rises to 15.6% when only consider-
ing developing countries [2]. A Swedish study found that 20–35% of pregnant women evalu-
ated their own emotional and physical health as poor [3], while 29% of the participating
mothers in a survey of a pregnant population from the Copenhagen University Hospital
answered “yes” when asked whether they were feeling anxious, stressed or depressed and/or
had experienced a traumatizing life event during their pregnancy (unpublished data from LM,
n = 48).
Several studies have linked maternal psychosocial stress during pregnancy to a range of
effects, both in pregnancy, showing effects on incidence of pre-eclampsia [4] and placental
weight [5], in newborn offspring in the infant cortisol response [6] and also later in childhood
when studying stress reactivity [7], offspring pediatric disease [8] and asthma and atopic der-
matitis [9]. Epidemiological studies of the effects of stress during pregnancy have focused on
neurological effects and changes in behavior [6;10;11], and immune system effects such as
asthma and allergies [9;12;13].
Elevated cortisol levels in plasma have been used as a biomarker in diagnosis of chronic
stress [14]. In pregnant women the plasma concentrations of cortisol are elevated by the feed
forward mechanism of the corticotropin-releasing hormone produced by the placenta, and
elevated plasma cortisol is therefore a poor biomarker during pregnancy [15;16]. During the
first two trimesters of pregnancy, the serum cortisol levels in the fetus are low, except for a
peak around gestation week 10 to counteract the effects of hormones from newly formed fetal
adrenal tissue. In the third trimester, the fetal serum cortisol levels rise, and is at a maximum
at term due to a decline in the placental cortisol metabolizing activity, and the production of
cortisol by the fetal adrenal glands [17]. High levels of cortisol during pregnancy have anti-
inflammatory and catabolic properties in both the fetus and the pregnant woman.
The mechanisms of maternal psychosocial stress affecting the fetus during pregnancy are
assumed to be regulated by placental transfer of hormones, through changes in the expression
of placental receptors and enzymes (for reviews, see [18;19]). The placental barrier consists of
different cell layers in the human placenta and the placental cell layer most representative of
the placental transport and metabolism of hormones is the syncytiotrophoblast. This cell layer
expresses the enzyme 11β-HSD2, expressed in tissues that require protection from cortisol,
which transforms 80–90% of the maternal cortisol to cortisone passed on to the umbilical and
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fetal blood [17;20]. The activity of this enzyme has been linked to the effect of maternal psy-
chosocial stress on the offspring, as the metabolic activity of this enzyme protects the fetus
from the high maternal cortisol plasma levels (for a review see [21]). The placental gene and
mRNA expression of 11β-HSD2, as well as the epigenetic methylation deactivation of 11β-
HSD2, has been studied in relation to maternal stress [10;22;23]. The activity of 11β-HSD2 can
be studied by comparing cortisol and cortisone concentrations in maternal and fetal blood.
Previously, the ratio of maternal cortisol to fetal cortisol and the fetal or maternal cortisol-cor-
tisone ratio have been used as a measure of activity of this enzyme [24–26].
Most studies have been performed in populations of pregnant women who have been diag-
nosed with depression or have other mental health problems. In contrast, the stress variables
in our study are self-reported experiences of depression, anxiety and stress during pregnancy,
measured using questionnaires, including selected personality traits of respondents, as these
traits can affect the experience of and emotional reactions to stress exposure [27;28]. The aim
of the Maternal Stress and Placental Function project is to investigate the effect of prenatal
maternal psychosocial stress on the adjusted fetal cortisol exposure (AFCE) in a normal preg-
nant population.
AFCE represents the relative amount of cortisone produced by the placenta measured in
fetal blood in relation to how much cortisol the placenta has let pass un-metabolized from
maternal blood, corrected for the interindividual differences of these hormone levels in the
population–i.e. the placental exposure. The AFCE gives us a measure of the activity of the
enzyme 11β-HSD2 until the time of birth. An increase in the AFCE represents a relative
increase in fetal cortisol exposure.
Materials and methods
The current study is a part of the Maternal Stress and Placental Function project, conducted in
Copenhagen, Denmark. Participants were pregnant women giving birth at Copenhagen Uni-
versity Hospital, where the Department of Obstetrics has around 6000 births a year, of which
approximately 22% are Caesarean Sections. Patients admitted to the department are healthy
women and women with medical and obstetric complications, as well as women with psycho-
social problems. We aimed to investigate the normal population and the criterion for exclusion
was age less than 18. The project was approved by the Regional Scientific Ethical Committee of
Copenhagen (H-15006254) and the Danish Data Protection Agency (2015-41-4208). All
women were informed about the aim of the study and gave written informed consent.
Recruitment
Recruitment was carried out at four locations connected to the hospital: at the information
meetings for all pregnant women; at information meetings for women giving birth to their
first child; in the waiting room at the midwives’ offices; and at the information meeting specifi-
cally for women giving birth by planned cesarean section. The pregnant women were
instructed to answer four written questionnaires in order to measure: 1: relevant personal fac-
tors such as socioeconomic status, use of medication, smoking, and alcohol consumption dur-
ing and before pregnancy, 2: pregnancy-related anxiety, 3: personality, and 4: prevalence of
prenatal depression, anxiety and stress. Over a period of 11 months from June 2015 to May
2016, out of 2058 invited families, 562 decided to participate in the study. Only participants
with returned questionnaires and successful blood sampling from both mother and umbilical
cord directly after birth were included in this study, resulting in 273 participants. Sampling
was primarily conducted from Monday to Sunday in the timeframe 7 am to 8 pm.
Maternal stress and placental function
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Population characteristics
Information regarding lifestyle, BMI, parity, chronic illness, pregnancy complications and
medication used during pregnancy was obtained via self-reported questionnaires, and vari-
ables connected to the birth and the infant were collected via hospital records. A variable rep-
resenting the strain of birth (birth strain) was constructed taking into account the length of
active labor (vaginal birth 1 point, active labor >12 hours: 2 points, pushing contractions>1
hour: 2 points), augmentation of labor using synthetic oxytocin: (1 point), the use of pain alle-
viation (non-medical: 1 point or medical: 2 points) and the interventions used during delivery
(forceps or vacuum assisted: 1 point or acute section: 2 points). Resulting in a birth strain
score of 0 points for elective caesarean section, and a possible score of 1 to 10 points for vaginal
births. Placental symmetry was calculated as the measure of the widest place on the placental
diameter minus the shortest place on the placental diameter.
Psychometric measures
Maternal state stress was defined as the individual degree of depression, anxiety and stress
experienced during the pregnancy, pregnancy- and birth-related thoughts and anxiety, and
the experience of major life events during pregnancy. These were assessed using the Depres-
sion Anxiety Stress Scales (DASS), Pregnancy Related Anxiety (PRA), and a Major Life Events
question. DASS (DASS-42 translated to Danish by Dr Mikael Thastum from the University of
Aarhus) contains 42 questions, with depression, anxiety and stress represented by 14 items
each [29]. Items were scored 0 to 3 and total scores for each condition were categorized into
normal, mild, moderate and severe according to the DASS manual [30]. PRA were assessed
using a Danish translation of the 10-item Pregnancy-Related Thoughts (PRT) questionnaire
[31] and an additional four items (Birth-Related Thoughts, BRT) (see S1 Table) used by the
Copenhagen University Hospital to screen for severely anxious pregnant women. The PRT
questions were answered on a four-point Likert scale rating from “not at all (1)” to “very much
(4)” and the BRT questionnaire had a five-point scale from 0 to 5. The BRT was transformed
and integrated into the PRT with an acceptable internal consistency (α = 0.79), producing a
measure of Pregnancy-Related Anxiety (PRA). PRA was categorized into four groups based on
total scores in this study: 10–19 defined “no PRA”, 20–25 “some PRA”, 26–31 “moderate
PRA” and scores more than 31 “high PRA”. The Major Life Events question, “have you experi-
enced any major life events during your pregnancy that have led to changes in your state of
mind?”, was answered “yes/no” and defined with examples from the Holmes-Rahe stress
inventory of Major Life Events [32].
Maternal trait stress was assessed using the Danish version of the NEO-FFI inventory, a
well-known measure of the “big five” personality traits of Neuroticism, Extraversion, Open-
ness, Conscientiousness and Agreeableness [33]. The two traits of Neuroticism and Conscien-
tiousness were individually included in the analyses as possible confounders. A high score for
Neuroticism was defined as the upper 25% of scores (upper quartile) and a low score on Con-
scientiousness as the lowest 25% of scores (lower quartile).
Sampling
The participants donated a maternal 20 ml blood-sample and 20–30 ml umbilical cord blood
directly after birth. Blood was sampled by venipuncture into 10 ml vacuum tubes containing
EDTA, centrifuged for 10 minutes at 4000g without brake and the plasma was collected and
stored at -80˚C until analysis. All sampling and handling times and times of freezing the sam-
ples were noted.
Maternal stress and placental function
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Analysis of concentration of cortisol and cortisone
The quantification method of cortisol and cortisone is described in detail in the supporting
material (S1 File).
In brief: for each analyte, specific isotopically labelled internal standards (IS) (cortisol-d4
for cortisol and cortisone-d8 for cortisone) were used. The working solution of IS was prepared
fresh and consisted of 25 mL 50 mM sodium diphosphate dibasic pentahydrate, pH unad-
justed and 1.5 mL of IS mix from Chromsystems. The simplified liquid extraction method was
adapted.
Sample analysis was performed using a Waters (Milford, MA, USA) Acquity UPLC system
with a Kinetex 2.6 μm EVO C18 column (100Å 100x2.1 mm; Phenomenex, Torrance, CA,
USA). Column temperature was 50˚C, flow rate was 500 μl/min, and injection volume was
5 μl. The total analysis time was 9 minutes per sample. The mobile phase was a gradient of a
mixture of an aqueous mobile phase 0.1% NH4OH (v/v) in water (mobile phase A) and an
organic phase containing 0.1% NH4OH (v/v) in MeOH (mobile phase B).
The passing criteria were defined by measuring the concentration of cortisol and cortisone
in QC samples: In each batch, a set of matrix match QC samples were run in order ensure the
validity of the batches (low and high). The low control contained cortisol and cortisone at con-
centrations of 73 nmol/L and 5,5 nmol/L respectively. The high control contained cortisol and
cortisone at concentrations of 494 nmol/L and 81,5 nmol/L respectively. If the high controls
were within ±15% of the target values and low controls were within ±20% of the target value
the batch was considered acceptable. The QC values for the batches that were deemed accept-
able the QC values were within ±10% of the target value.
Outcomes
The primary outcome was cortisol-cortisone ratio between umbilical cord (fetal) blood and
maternal blood, referred to as AFCE (adjusted fetal cortisol exposure):
AFCE ¼
Fetal cortisolcortisone
Maternal cortisolcortisone
Maternal and fetal plasma cortisol and cortisone concentrations were included as secondary
outcomes.
Statistical analyses
In order to test for normality in the distribution of cortisol, cortisone and AFCE levels, the
Shapiro-Wilk test was performed and yielded a non-normal distribution. Log-transformation
was performed and only log fetal cortisol did not obtain normal distribution.
All analyses were performed using linear regression, with stepwise adjustment for con-
founders and covariates. The associations were assessed in five models. Model 1 was unad-
justed, and the other models were adjusted with an increasing selection of potential
confounders and intermediate variables: Model 2: personal traits (maternal age, BMI before
pregnancy (categorized 1: underweight<18.5kg/m2, 2: normal: 18.5–24.9kg/m2, 3: overweight:
25–29.9kg/m2, and 4: obese:>30kg/m2), parity (primipartum) including maternal trait stress
(neuroticism (upper quartile) and conscientiousness (lower quartile)), Model 3: lifestyle
(smoking during pregnancy, alcohol during pregnancy), Model 4: health (chronic disease, ges-
tational complications (normal birth), asthma medication) and Model 5: delivery (gestational
age, gender, mode of delivery (caesarean section or vaginal birth), birth strain, placental weight
(log), placenta symmetry (log), time from delivery to maternal blood sample) (see Table 1).
Maternal stress and placental function
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The measure of effect is the exponentiated regression coefficient of the exposure– 10^ β–
which, because of the log-transform of the outcome, is the factor by which the outcome is mul-
tiplied for a unit increase of the exposure.
ANOVA was used to test the differences in hormone levels and AFCE between vaginal
birth and elective caesarean groups, when stratifying the data by birth mode. All statistical
modeling and testing was performed in IBM SPSS Statistics 24. Descriptive results are pre-
sented categorically with frequency tables and numerically as mean ±SD. A p-value less than
0.05 is deemed statistically significant.
Results
Descriptive data, lifestyle, self-reported health and birth-related outcomes are shown in
Table 2. Caesarean sections were the birth method of 151 (55%) women. Seventy (26%) preg-
nant women reported having one or more chronic diseases, primarily asthma or allergies and
various metabolic, gastrointestinal and dermatological diseases (see Table 2).
Correlations between maternal and fetal levels of cortisol and cortisone are shown in Fig 1.
The results from DASS-42, PRA and Major Life Events questionnaires are shown in Fig 2.
AFCE
Results from the regression analysis (10^β (CI) and p-value for each category of DASS-42,
PRA and Major Life Events) are presented in Table 3. Outcomes from the DASS were analyzed
as dichotomous “normal” and “increased” due to small group sizes in the “moderate” and
“severe” categories (see Fig 2).
A test of correlation between the primary outcome and time from delivery to maternal and
fetal blood sample collection was performed using the Pearson Correlation and showed
Table 1. Epidemiological model including exposures, potential confounders and outcome variables.
Exposure Potential confounders Outcome
Maternal state stress
DASS-42a
-Depression
-Anxiety
-Stress
PRAb
Major life events
Model 2 Personal traits
Age
BMI
Parity
Maternal trait stress:
NEO-FFI -neuroticism,conscientiousness
Primary outcome: AFCEc
Secondary outcomes:
Plasma concentrations of maternal and fetal cortisol and cortisone
Model 3 Lifestyle
Smoking
Alcohol
Model 4 Health
Chronic disease
Gestational complications
Asthma medication
Model 5 Delivery
Gestational age
Gender
Delivery mode
Placental weight
Placental symmetry
Delivery to maternal blood
aDASS-42 is the results from the depression anxiety stress scales.
bPRA is the results from the questionnaire on pregnancy related anxiety.
cAFCE is the adjusted fetal cortisol response.
https://doi.org/10.1371/journal.pone.0207184.t001
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Table 2. Characteristics of the study population (n = 273).
Variable Frequency (%)
Maternal age (in years), mean [range] 33.6 [23–49]
Parity, frequency
First child 124 (45)
─ twins 6 (2)
Second child or more 149 (55)
Smoking during pregnancy
No 254 (93)
Yes 19 (7)
Alcohol during pregnancy
No 185 (68)
Yes 85 (31)
BMI before pregnancy, kg/m2
Underweight <18.4 14 (5)
Normal weight 18.5–24.9 193 (71)
Overweight 25–29.9 40 (15)
Obese >30 17 (6)
Working hours
Part time (<30 hours/week) 7 (3)
Full time (�30 hours/week) 166 (61)
Student 17 (6)
Not working 9 (3)
Changing hours 59 (22)
Self-reported health
Chronic diseases reported
Metabolic (DM type 1 & 2, hypo/hyper-thyroidism, thyroiditis, Graves, PCOS, hepatitis
B)
23
Asthma 17
Other immunologic (allergy, hives, immunodeficiency) 11
Skin, joint, bone and connective tissue (Atopic dermatitis, lichen planus, psoriasis,
vitiligo, Ehlers Danlos hypermobile, arthritis, endometriosis, adenomyosis, fibromuscular
dysplasia, Takayasu arteritis, scoliosis, BRCA1)
16
Gastrointestinal (Morbus Crohn, IBD, Celiac disease, colitis ulceros, anal fissure, hiatus
hernia, familial polyposis)
12
Neurological (Depression, Epilepsia, MS relapsing, Impaired vision, papaplegia) 10
Cardiovascular (Stickler syndrome, long QT, Brugada syndrome, Factor V Leiden homo,
Prothrombin mutation, cardiolipin antibodies, factor II mutation, Gilbert Meulengracht
syndrome)
7
Gestational complications reported
Fertility treatment (IVF, ICSI, Egg-donation) 4
Pregnancy related body burden (Pelvic instability, Hyperemesis, Intrahepatic Cholestasis
of pregnancy, GDM)
20
Cardiovascular (Thrombosis, hypertension, arrythmia, arteritis) 11
Gastrointestinal (Obstipation, reflux) 5
Uterus, ovaries, placenta (Pre-ecclampsia+previous, placenta previa, hemorrhaging,
Braxton Hicks, ovary cyste, double uterus, previous trakelektomi, abdominal cerclage,
swollen labia minor)
16
Fetal (Gemelli, RhD immunization, IUGR+previous, Breech position, premature birth
risk, CCAM in fetal lung, fetal thrombocytopenia)
14
Neurological (Stress, anxiety, insomnia) 5
Pain (Pain undefined, pelvic pains, backache, headache, migraine, tooth operation) 10
(Continued)
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positive correlation between time from delivery to maternal blood sample and log AFCE
(r = 0.16, p<0.01). The maternal time variable was therefore included in step 5 of the regres-
sion model.
Table 2. (Continued)
Infections (UTI, pneumonia, sinus infection, mycoplasma genitalia, abcess, tick bite,
influenza, nasal congestion)
18
Medication during pregnancy (n = 271)
No 175 (64)
Yes (Chronic: Loratidin, insulin, methformin, eltroxin, Imurel,Ursochol, Omeprazol,
betablocker, Innohep, Setralin, Levetiracetan, Methyldopa, Lutinus, Privigen, Acute:
paracetamol, acetyl salicylic acid, ibuprofen, kodein, metadon, Cyclokapron,Promethazin,
melatonin, antibiotics)
96 (35)
Asthma medication (Ventoline, Pulmicourt, Salofalk, Oxis turbohaler, Spirocourt,
bricanyl, Fuitiform, duoresp)
17
Gestational age, mean ±SD [range], weeks (n = 260) 39.4 ±1.2 [36–42]
Delivery mode
Vaginal (including acute Caesarean section) 122 (45)
Caesarean section (elective) 151 (55)
Birth interventions vaginal births
Epidural in vaginal birth 40 (33)
Vacuum or forceps 11 (9)
Acute Caesarean section 7 (6)
Child gender
Male 134 (49)
Female 135 (50)
Anthropometrics, mean ±SD [range]
Birth weight, g 3464 ±487 [2400–5696]
Child length, cm 51.5 ±2.2 [47–59]
Head circumference, cm 35.2 ±1.5 [31–39]
Placenta weight, mean ±SD [range], g 712 ±172
[465–1475]
Apgar score after 5 minutes
10 250 (92)
<10 11 (4)
Sample times, mean ±SD [range], hours
Delivery to umbilical cord sample 0:19 ±0:16
[0:01–2:04]
Delivery to maternal blood sample 0:55 ±0:24
[0:05–2:53]
Outcome values, mean ±SD [range]
Maternal cortisol, nmol/L 1276.6 ±528.9 [278.7–
3162.0]
Fetal cortisol, nmol/L 118.6 ±111.2 [20.7–
585.9]
Maternal cortisone, nmol/L 132.9 ±33.4 [30.4–
230.4]
Fetal cortisone, nmol/L 555.5 ±340.1 [116.2–
1820.8]
AFCE (fetal-maternal cortisol-cortisone ratio) 0.024 ±0.017 [0.00–
0.14]
https://doi.org/10.1371/journal.pone.0207184.t002
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Significant results were seen for the primary outcome AFCE and PRA with approximately
1.5 times increase in AFCE for a unit increase in PRA in models 1 (10^β = 1.349, p = 0.032),
and when adjusting for personal traits in model 2 (10^β = 1.455, p = 0.013), lifestyle in model
3 (10^β = 1.462, p = 0.012) and health in model 4 (10^β = 1.466, p = 0.013), but the increase
was no longer statistically significant when adjusting for delivery factors in model 5 (10^β =
1.315, p = 0.080) (see Table 3). When stratifying data according to delivery mode, the effect of
PRA on AFCE was found primarily in vaginal delivery (model 5: elective Caesarean section:
10^β = 1.102, p = 0.638, vaginal delivery: 10^β = 1.549, p = 0.050) (See S2 Table). No other
Fig 1. Fetal and maternal cortisone and cortisol. The y-axis is log-scale. Both fetal and maternal plasma cortisone (blue circle) and fetal and maternal cortisol
(orange square) values correlate.
https://doi.org/10.1371/journal.pone.0207184.g001
Maternal stress and placental function
PLOS ONE | https://doi.org/10.1371/journal.pone.0207184 November 15, 2018 9 / 18
exposure variable showed any significant effect on AFCE. For all exposure variables (state-
depression, anxiety and stress, PRA and Major life events) in model 5, the possible confound-
ers showing a significant effect on AFCE were delivery mode (10^β = 0.49, p = 0.012, less
AFCE in caesarean section), birth strain (10^β = 1.77, p = 0.034, more AFCE with higher birth
strain) and placental weight (10^β = 1.42, p = 0.020, more AFCE in larger placentas) (see S3
Table).
Plasma concentrations of cortisol and cortisone
As with AFCE, the only exposure variable showing significant effects in models 1–4 was PRA,
which was significantly associated with maternal plasma cortisol (10^β = 0.72, p = 0.022 in
model 4) and fetal plasma cortisone (10^β = 0.74, p = 0.024 in model 4), but not in model 5
when adjusting for delivery variables.
Like for AFCE, a significant confounder in the exposure effect relationship was delivery
mode for all exposure variables, in maternal cortisol (10^β~3.3, p<0.000), and fetal cortisol
(10^β~3.1, p<0.000) and cortisone (10^β~4.5, p<0.000).
For the two fetal outcomes fetal cortisol and fetal cortisone, there was a significant effect of
parity; more fetal cortisol (10^β~1.3, p~0.004) and fetal cortisone (10^β~1.3, p~0.004) in first
Fig 2. Categorical distribution of the study population based on DASS scores, Major Life Events and PRA. The study population divided into groups according to
severeness of maternal (A) Depression, (B) Anxiety and (C) Stress based on the Depression Anxiety and Stress Scales, (D) Major Life events and (E) Pregnancy related
anxiety (PRA).
https://doi.org/10.1371/journal.pone.0207184.g002
Maternal stress and placental function
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pregnancies. Cortisone in both maternal and fetal plasma was significantly correlated with
maternal age (10^β~0.6, p~0.001) and (10^β~0.8, p~0.03). In maternal cortisol and fetal corti-
sone there was an effect of time from delivery to maternal blood sample, with a reverse correla-
tion (10^β~0.6, p<0.000) and (10^β~0.8, p~0.03). The only effect of personality was seen in
maternal cortisone, were there was a significant effect of conscientiousness, with an increased
content of cortisone with increased conscientiousness (10^β~1.4, p~0.03).
Discussion
Maternal state stress and placental cortisol metabolism
In our study, we saw an association between PRA and our primary outcome measure of pla-
cental cortisol metabolism: the AFCE; higher fetal cortisol exposure in the group with the high-
est scores of pregnancy related anxiety, though the association became non-significant when
adjusting for mode of delivery, birth strain and placental weight. Exposure to state-depression,
-anxiety or -stress and Major Life Events were not correlated to AFCE, even when adjusting
for a range of personal traits, lifestyle, health and birth-related factors.
The association between PRA and AFCE resembles the findings of Glover et al. 2009 [24],
La Marca-Ghaemmaghami et al. 2014 [25], and Hellgren et al. 2016 [26], who found effects of
maternal state stress on ratios of cortisol and cortisone in maternal and fetal saliva, serum and
amniotic fluid. In the study by Glover et al., the correlation between maternal and amniotic
cortisol was significantly different when the mothers were grouped according to levels of state
and trait anxiety. The cortisol levels in mother and amniotic fluid were more similar in more
anxious mothers, suggesting lower feto-placental 11β-HSD2 activity [24] La Marca-Ghaemma-
ghami et al. found that maternal salivary responses to the acute stress of amniocentesis, but
not self-reported state or trait anxiety, were significantly and positively related to the amniotic
fluid cortisone and to amniotic fluid cortisone/(cortisol+cortisone) ratio. This suggested that
the acute stress reactivity of the pregnant woman was positively correlated with activity of the
placental 11β-HSD2 [25]. Both these studies were performed at gestational week 16–17 and
Table 3. Regression coefficients (10^β), confidence intervals (CI) and levels of significance (p-value) from the five-step regression analysis of state stress exposures
and AFCE. The data are presented as 10^β representing the factor by which the mean AFCE is multiplied for each unit increase in exposure.
AFCE Model 1a Model 2ab Model 3abc Model 4abcd Model 5abcde
Exposure 10^β (CI) p 10^β (CI) p 10^β (CI) p 10^β (CI) p 10^β (CI) p
State-depression 0.789
(0.581–1.040)
0.090 0.783
(0.570–1.549)
0.093 0.774
(0.561–1.035)
0.082 0.757
(0.545–1.019)
0.065 0.787
(0.570–1.054)
0.103
State-anxiety 0.946
(0.805–1.156)
0.694 0.986
(0.818–1.202)
0.927 0.993
(0.820–1.208)
0.963 0.995
(0.820–1.211)
0.973 0.957
(0.802–1.178)
0.773
State-stress 0.877
(0.746–1.109)
0.352 0.875
(0.729–1.130)
0.383 0.867
(0.723–1.125)
0.355 0.865
(0.721–1.125)
0.355 0.910
(0.748–1.167)
0.546
PRA 1.349�
(1.007–1.183)
0.032 1.455�
(1.023–1.219)
0.013 1.462�
(1.026–1.222)
0.012 1.466�
(1.023–1.225)
0.013 1.315
(0.991–1.186)
0.080
Major Life Events 1.033
(0.869–1.194)
0.816 1.035
(0.867–1.202)
0.806 1.380
(0.863–1.199)
0.829 1.038
(0.865–1.208)
0.799 1.030
(0.863–1.202)
0.834
a Unadjusted
b Adjusted for age, BMI, parity, neuroticism upper quartile and conscientiousness lower quartile
c Adjusted for smoking and alcohol during pregnancy
d Adjusted for asthma medication, chronic disease and gestational complications
e Adjusted for gestational age, gender, delivery mode, birth strain, placenta weight and symmetry, and time from delivery to maternal blood samples.
�statistically significant.
https://doi.org/10.1371/journal.pone.0207184.t003
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used amniotic fluid as the biomarker for the fetoplacental unit. Hellgren et al. studied maternal
serum cortisol and cortisone ratio in pregnant women with psychiatric morbidity, determined
by self-reported anxiety and depression. The study found a significantly positive correlation
between cortisone to cortisol ratio and infant birth weight, driven by maternal psychiatric sta-
tus [26]. All of these studies included fewer participants than our study but with a potentially
higher stress exposure: women with indications for amniocentesis and antenatal psychiatric
morbidity, and did not adjust for the covariates of birth method, placenta weight or personality
traits. When correcting for delivery mode, and placental weight in model 5, our correlation
between PRA and AFCE was no longer statistically significant, although still showing a ten-
dency with a p-value of 0.08. Interestingly, when stratifying the data by delivery mode the cor-
relation between PRA and AFCE in the vaginal delivery group was borderline significant in
model 5 with a p-value of 0.05.
When studying the enzyme 11β-HSD2 directly in placental samples, one significant
finding relating to fetal cortisol exposure, from a study by Monk et al., was the association
between DNA-methylation of 11β-HSD2 and maternal stress measured using the Per-
ceived Stress Scales, which in turn was associated with lower fetal coupling [10]. A study
by Stroud et al. (2016) also found altered placental 11β-HSD2 activity, although with preg-
nant study participants diagnosed with major depressive disorder. In one-month-old
daughters of depressed mothers, salivary cortisol was increased by 50–75% and this effect
was mediated by the placental 11β-HSD2-methylation [6]. These methylation studies pro-
pose a mechanism by which the activity 11β-HSD2 enzyme is downregulated by prenatal
maternal stress. The gene expression of 11β-HSD2 has also been correlated to prenatal
maternal anxiety in studies by O’Donnell et al. (2011) and Seth et al. (2015), demonstrat-
ing direct downregulation of gene expression [22;23]. In the study by O’Donnell et al.,
placental samples were donated and state and trait anxiety was reported from pregnant
women undergoing caesarean sections, and here a significant negative correlation was
seen between 11β-HSD2 gene expression and maternal trait anxiety, with an approxi-
mately 30% lower expression in the high-anxiety group. An association was also seen for
the state anxiety exposure parameter, but not for self-rated Edinburgh Postnatal Depres-
sion Scale (EPDS) scores. However, when looking at enzyme activity in a subgroup of the
same study, a significant negative correlation was found for the EPDS score, and a signifi-
cantly higher enzyme activity in the placenta was found for female fetuses [23]. The EPDS
score and the state and trait depression were also found to correlate negatively with 11β-
HSD2 gene expression in the study by Seth et al., although this was not statistically signifi-
cant. Here the correlation was particularly prominent during late gestation, as EPDS
scores and state anxiety scores showed significant improvement between trimesters [22].
These studies show substantial differences in the exposure and outcome measures in the
study of prenatal stress and the effects on the metabolism of cortisol in the placenta. The mea-
sures of exposure range from self-reported depression, anxiety and stress using different ques-
tionnaires or interviews, to diagnosed major depression disorder, and the outcome measures
ranges from gene expression and methylation to different measures of the activity of the
enzyme 11β-HSD2. The use of statistical methods and inclusion of covariates also differ
among these studies. In our study we have calculated the AFCE, which takes into account both
the maternal and fetal cortisone and cortisol, and therefore represents the activity of the pla-
cental 11β-HSD2 up until and including the birth. Although there are differences between the
mentioned studies, some associations between maternal psychosocial stress during pregnancy
and placental 11β-HSD2 activity are found.
Maternal stress and placental function
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Questionnaire predictivity in a pregnant population
In our study, exposure to PRA showed a significant effect on AFCE, maternal plasma cortisol
and fetal plasma cortisone in the first four models and a trend in the adjusted model 5. Data
for PRA were obtained using results from questionnaires that were created for a pregnant pop-
ulation and could therefore be sensitive to detecting stressors not found when using question-
naires that are not validated for studies of pregnant women. The data from PRA were also
categorized by stress level based on answers from our study population. In the DASS-42 we
used the categories given, and most of our population was in the no or low state stress catego-
ries. Differences between scales were also found in other studies. For example, Edinburgh
Postnatal Depression Scale results did not correlate with 11β-HSD2 gene expression in the
study by O’Donnell et al. [23], although state and trait anxiety measured by other scales
showed correlation between the most and least anxious groups.
Factors affecting the outcome parameters
Mode of delivery, birth strain and placenta weight were the statistically significant factors
affecting the correlation of our state stress with AFCE. Mode of delivery and birth strain were
expected important factors due to the physical strain and pain of vaginal birth, potentially
increasing maternal cortisol, as also shown by Stjernholm et al. [34]. Indeed, cortisol has been
suggested as a biomarker of stress during human term labor [14]. We found that when stratify-
ing our data according to delivery mode, the effect of state stress PRA was predominantly seen
in the group that gave birth by vaginal delivery; the effect was greater than the effect seen in
the unstratified data, and borderline significant (p = 0.050) although the group size was more
than halved. All the measured hormones had a significantly higher mean in the vaginal birth
group (p<0.000), but the AFCE had a lower mean in the vaginal birth group than the elective
Caesarean group (p = 0.016). Therefore, it seems although the hormone levels were higher dur-
ing vaginal birth, the relative cortisol exposure to the fetus was lower, and the maternal effect
of PRA on the placenta was greatest in women delivering by vaginal birth. Delivery mode was
also a significant factor in most models comparing the effect of our state stress parameters on
fetal and maternal cortisol and cortisone. The only outcome for which delivery mode was not
a significant factor in the model was maternal cortisone, where maternal age was a significant
factor. Cortisone has shown to be age-related caused by increase in 11β-HSD1 enzyme activity
with age [35].
The sampling strategy in our study was to take simultaneous (at birth) samples from mother
and fetus (umbilical cord) to represent placental cortisol metabolism during pregnancy. The
significant effect of delivery mode on our exposure-outcome models demonstrates the impor-
tance of including birth method as a covariate when studying the metabolic capacity of the pla-
centa during pregnancy using samples taken directly after birth in both caesarean and vaginal
deliveries. Our study population had an overrepresentation of deliveries by caesarean section
(55% versus 22% reported by the Department of Obstetrics, Copenhagen University Hospital).
This overrepresentation was due to our recruitment strategy, in which the majority of partici-
pants were enrolled at meetings for women opting for an elective caesarean section.
Placenta weight is linearly related to the surface area of the villous tissue, a main determi-
nant of the capacity to transport nutrients, as well as maternal plasma levels of placental hor-
mones [36]. The weight of the placenta has, along with other features of placental morphology,
been shown to be a more sensitive measure of pregnancy complications, maternal nutritional
status, and later health effects on the child than the birth weight [37]. It is therefore reasonable
to assume that the size of the placenta also has an influence on the metabolic capacity of the
placenta, but in the case of 11β-HSD2 activity, there seems to be no relation to birth weight or
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placental weight in two studies including 111 and 27 term placentas from normal births
[38;39]. In contrast, the size of the placenta had an effect on the correlation between the state
stress exposure and the outcome measure of placental cortisol metabolism AFCE in our study.
This implies that even though the relative enzyme 11β-HSD2 activity is not increased in larger
placentas, there seems to be a mediating effect of size on the placental metabolic capacity.
It is worth noticing that birth strain and placenta weight showed a significant effect on our
outcome of AFCE independent of the four measures of maternal and fetal cortisol and corti-
sone. This shows that the ratio of cortisol and cortisone on fetal and maternal side can be a sen-
sitive proxy measure of placental function, and what factors affect this function.
Population and method
Our study population is a normal relatively unselected section of the population, and therefore
represents normal pregnant women subjected to everyday stressors and pregnancy anxiety.
We have not focused on diagnosed psychiatric morbidity, and therefore our results are appli-
cable to the general population. Different diseases as well as medication can affect the cortisol
levels of a pregnant woman. We did not see an effect for asthma medication, which indicates
that this local use of corticosteroids does not interfere with placental metabolic function.
Out of the initial 2058 persons contacted, the final study included 273 participating
mother-placenta-child pairs. In other studies demonstrating the effects of prenatal anxiety, the
numbers of participating women were 56 [40], 66 [41] and 262 [24], which suggests that our
population size was sufficient to demonstrate differences in exposures and outcomes. A power
calculation carried out after the data collection revealed that with our data material we were
able to detect differences in AFCE at approximately 13% between normal and increased levels
of anxiety, stress, pregnancy-related thoughts and life events with 80% power, which we con-
sider acceptable and relevant. The depression variable that had the smallest group size in the
increased group in our study (measured by DASS-42), needed a difference of more than 20%
in AFCE between groups before showing sufficient power to detect a statistically significant
difference. Our population did not include clinically depressed mothers or mothers with
severe mental health issues, making it less likely that we would find critical physiological differ-
ences in our population. When planning this study there was a focus on ease of participation,
resulting in the decision to sample only at birth and to ask participants to fill in questionnaires
at only one point in time during the pregnancy. We believe that this increased the participation
rate and aided in recruiting women that would not participate in more time-consuming
studies.
We have focused on studies done in humans. When studying reproductive effects and pla-
cental transfer it is difficult to extrapolate the effects in animals to effects in humans. This is
due to the many differences between pregnancy in the majority of animal and human preg-
nancies, related to (but not limited to) placental morphology, developmental stage at birth,
and child development. The human HPA axis functions differently in pregnancy from most
animal models because of the human placental production of corticotropin-releasing hormone
and, as shown by Heussner et al., there are relevant species differences between the placental
steroid metabolisms of humans and rats, which should be considered when attempting to
transfer results from rodents to humans [42]. It is therefore not certain that the effects
observed in animal experiments, if any, would be similar to those observed in humans.
Conclusion
Associations between Pregnancy-Related Anxiety (PRA) and adjusted fetal cortisol exposure
(AFCE) were seen in our study population of 273 mother-fetus dyads, and these associations
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were strongest in the vaginal delivery group. The AFCE was significantly associated with pla-
cental weight independently of the individual plasma hormone levels, which supports that the
AFCE is a measure of placental function. The PRA questionnaires were shown to be more sen-
sitive to the target population than the DASS-42 questionnaire, which demonstrates the
importance of validating stress scales to be used in a population of pregnant women.
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